Evidence map›Paper›PMID 40817184›Full record

Trial reportJournal of neurology2025

Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples.

Michael Jaworski, Jacob Balconi, Celeste Santivasci, Margaret Youngs, Morgan Woodbeck, Nathan Zak, Sara Cruz, Bianca Weinstock-Guttman, Ralph H B Benedict

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael JaworskiDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.ORCID http://orcid.org/0000-0001-8184-4456
Jacob BalconiDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Celeste SantivasciDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Margaret YoungsDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Morgan WoodbeckDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Nathan ZakDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Sara CruzDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Bianca Weinstock-GuttmanDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Ralph H B BenedictDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, NY, USA. benedict@buffalo.edu.

Funding

CTSA UM1 State University of New York at BuffaloUM1TR005296 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Sanjay Sethi · 2025 to 2026
$8.3M
NCATS NIH HHS UM1 TR005296
6 · The paper itself

Abstract

Lower Conscientiousness is associated with cognitive decline, unemployment, and poorer health outcomes in both neurological and aging populations. This study evaluated a smartphone-based intervention to enhance Conscientiousness in people with multiple sclerosis (PwMS) and healthy aging (HA) adults. Initially, 38 PwMS and 22 HA participants completed baseline assessments (cognitive, personality, depression, and anxiety measures). Attrition and disease factors left 24 PwMS and 20 HA adults at the 12-week follow-up. Participants randomly assigned to the intervention arm received the "Conscientiousness Coach" app, which combined value identification, SMART goal development, smartphone-based tracking, and scheduled telehealth coaching sessions, whereas controls were wait-listed. ANCOVA for baseline scores showed a significant treatment effect on NEO-FFI Conscientiousness (p = 0.015) that remained after substituting age for diagnosis (p = 0.029). A lack of significant effects for group (PwMS vs. HA) and age indicated that treatment impact was consistent across both samples. Within the intervention group, paired-sample t-tests revealed large gains in the Conscientiousness domain (d = 0.93, p < 0.001) and moderate improvements in the Orderliness (d = 0.67, p = 0.007) and Dependability (d = 0.52, p = 0.030) facets, with no change in wait-list controls. No treatment effects emerged for Neuroticism, depression, or anxiety, underscoring the trait-specific nature of the intervention. Results suggest that targeted digital interventions can favorably impact personality and enhance quality of life. Future study will examine use of AI to replace the behavioral coaching component of this intervention and its long-term impact on personality.

Indexed as

Healthy AgingMobile ApplicationsMultiple SclerosisPersonalitySmartphoneAdultAgedFemaleHumansMaleMiddle AgedTelemedicineConscientiousnessFunctional impairmentHealth agingMultiple sclerosisPersonality interventionTelecoaching

Identifiers

PMID40817184
PMCPMC12356716

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.